HFM
IONS icon

Harvest Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

Harvest Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Sell
234
-4,582
-95% -$362K ﹤0.01% 404
2025
Q4 		$381K Buy
4,816
+3,070
+176% +$231K 0.01% 284
2025
Q3 		$114K Sell
1,746
-83
-5% -$4.05K ﹤0.01% 378
2025
Q2 		$72K Buy
+1,829
New +$59.9K ﹤0.01% 404

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harvest Fund Management's IONS Position: Q1 2026 in Review

Harvest Fund Management reduced its Ionis Pharmaceuticals (IONS) stake by 95% in Q1 2026, selling an estimated $362K and leaving 234 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #404.

Harvest Fund Management first reported a position in IONS in Q2 2025 and has held it in 4 quarters since. The position peaked at $381K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Harvest Fund Management held 234 shares of Ionis Pharmaceuticals worth $18K as of Q1 2026.
  • Harvest Fund Management sold 4,582 Ionis Pharmaceuticals shares in Q1 2026, an estimated $362K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Harvest Fund Management's portfolio in Q1 2026, its #404 holding.
  • Harvest Fund Management first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Harvest Fund Management's Ionis Pharmaceuticals position peaked at $381K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.